Hypertension og diabetes mellitus

Per Løgstrup Poulsen*, Klavs Wũrgler Hansen, Peter Haulund Gæde, Peter Rossing

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftReviewForskningpeer review


    The documentation for the beneficial effects of antihypertensive treatment in patients with diabetes is overwhelming. Most patients will require three or four antihypertensive drugs to achieve blood pressure (BP) goals. The regime should include an agent that blocks the renin angiotensin aldosterone system. Reduction in albuminuria during antihypertensive treatment is indicative of renal and cardiovascular protection. Thus, if the level of albuminuria remains high, the treatment should be intensified, even in the light of achieved BP goals. Options for intensification are dual blockade, supramaximal doses of ACE-I or ARB, or addition of aldosterone or renin-blocking agents. Long-term data are awaited regarding the optimal strategy for combination therapy. Patients on intensive antihypertensive treatment should be monitored regularly.

    Bidragets oversatte titelHypertension in patients with diabetes
    Sider (fra-til)2031-2034
    Antal sider4
    TidsskriftUgeskrift for laeger
    Udgave nummer24
    StatusUdgivet - 1 jun. 2009


    Udforsk hvilke forskningsemner 'Hypertension og diabetes mellitus' indeholder.